Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Trivalent MRKAd5 HIV-1 Gag/Pol/Nef	1,484
Overall Study	STARTED	Placebo	1,495
Overall Study	VACCINATED AT VISIT 2 (Dose 1)	Trivalent MRKAd5 HIV-1 Gag/Pol/Nef	1,484
Overall Study	VACCINATED AT VISIT 2 (Dose 1)	Placebo	1,495
Overall Study	VACCINATED AT VISIT 4 (Dose 2)	Trivalent MRKAd5 HIV-1 Gag/Pol/Nef	1,426
Overall Study	VACCINATED AT VISIT 4 (Dose 2)	Placebo	1,443
Overall Study	VACCINATED AT VISIT 7 (Dose 3)	Trivalent MRKAd5 HIV-1 Gag/Pol/Nef	1,328
Overall Study	VACCINATED AT VISIT 7 (Dose 3)	Placebo	1,361
Overall Study	COMPLETED	Trivalent MRKAd5 HIV-1 Gag/Pol/Nef	9
Overall Study	COMPLETED	Placebo	14
Overall Study	NOT COMPLETED	Trivalent MRKAd5 HIV-1 Gag/Pol/Nef	1,475
Overall Study	NOT COMPLETED	Placebo	1,481

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00095576/flow